You are now leaving the Kedrion Corporate site. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it. In addition as per local health authority Regulations, some of our products are not approved for sales, marketing or distribution in all countries.
NO
YES

HIGHLIGHTS

EVENTS

World Hemophilia Day 2021, Kedrion alongside patients

Today, more than ever, the company is close to those who are in a vulnerable condition

read more 

PLASMA & BIOTHERAPIES

Rh&Life, first subject included in the study

Two hundred pregnant women to be enrolled over five countries

read more 

PLASMA & BIOTHERAPIES

KIDCARES10, first patient enrolled in pediatric PI study

Thirty patients aged 2 to 17 years old to be enrolled over five European countries

read more 
  1. EVENTS - 30-10-2020

    Global Plasma Summit, Kedrion among the protagonists of the PPTA initiative

    Paolo Marcucci, President of the company, received the prestigious “Otto Schwartz” Award

    read more 
  2. EVENTS - 27-10-2020

    Covid-19, Kedrion supports a webinar on the management of Coagulopathy

    The purpose of the event is to improve understanding of one of the major complications associated with the virus

    read more 
  3. CORPORATE - 20-10-2020

    Kedrion Biopharma supports the launch of "Nature Italy"

    The Company reaffirms and strengthens its commitment to research and innovation

    read more 
  4. CORPORATE - 08-10-2020

    Kedrion alongside AICE on the 50th Ann. of the first AICE Triennial Conference

    The company supports the reading of a scientific study on the role of Factor VIII in the protection of the joints

    read more 

Pages

For more information please contact: [email protected]